uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrine Tumor Biology.
Show others and affiliations
2015 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 10, no 5, e0125553Article in journal (Refereed) Published
Abstract [en]

We previously detected and investigated nine altered microRNAs in small intestinal neuroendocrine tumor (SI-NET) tissues at different stages of disease. The aims of this study are to: 1) analyze whether SI-NET tissue microRNAs can be also detected in patient serum samples, 2) investigate a potential somatostatin analogs (SSAs) role on microRNA levels regulation in SSA-treated patient samples and 3) elucidate whether the serum microRNA levels in samples collected in different hospitals are predictable and steady. Our results show that tissue microRNAs are detectable in patient serum samples, and miR-96, -182, -183, -196a and -200a levels are lower in SI-NET untreated patients than in SSA-treated patients at all different stages. Conversely, miR-31, -129-5p, -133a and -215 levels do not show any difference in untreated SI-NET patients and SSA-treated patients at all different stages. Our findings also show that miR-200a exhibits an atypical behavior with high levels in both untreated and SSA-treated patients at liver metastasis stage, and unequivocally never at the earlier stages. Serum samples collected in two hospitals keep alike microRNA level pattern, elucidating that the results are not dependent on samples handling. In conclusion, SI-NET tissue microRNAs are always detectable in untreated and SSA-treated patient serum samples, SSAs play an unknown role in eliciting SSA-treated patients' microRNA levels higher than in untreated patients, and this study enlightens that miR-200a might be involved in the liver metastasis during SI-NET progression.

Place, publisher, year, edition, pages
2015. Vol. 10, no 5, e0125553
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-255077DOI: 10.1371/journal.pone.0125553ISI: 000353943400044PubMedID: 25942502OAI: oai:DiVA.org:uu-255077DiVA: diva2:820868
Available from: 2015-06-12 Created: 2015-06-12 Last updated: 2015-06-12Bibliographically approved

Open Access in DiVA

fulltext(831 kB)31 downloads
File information
File name FULLTEXT01.pdfFile size 831 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Li, Su-ChenÖberg, KjellGiandomenico, Valeria
By organisation
Endocrine Tumor BiologyEndocrine OncologyScience for Life Laboratory, SciLifeLab
In the same journal
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 31 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 143 hits
ReferencesLink to record
Permanent link

Direct link